FY2024 EPS Estimates for Bausch Health Companies Inc. Raised by Analyst (TSE:BHC)

Bausch Health Companies Inc. (TSE:BHC) – Investment analysts at Zacks Research lifted their FY2024 earnings per share estimates for Bausch Health Companies in a report released on Monday, July 22nd. Zacks Research analyst R. Department now anticipates that the company will earn $4.92 per share for the year, up from their prior estimate of $4.90. The consensus estimate for Bausch Health Companies’ current full-year earnings is $4.85 per share. Zacks Research also issued estimates for Bausch Health Companies’ FY2025 earnings at $5.77 EPS and Q2 2026 earnings at $1.58 EPS.

Bausch Health Companies (TSE:BHC) last issued its quarterly earnings results on Thursday, May 2nd. The company reported C$0.80 EPS for the quarter, missing analysts’ consensus estimates of C$1.02 by C($0.22). The business had revenue of C$2.90 billion during the quarter, compared to analysts’ expectations of C$2.98 billion. Bausch Health Companies had a negative net margin of 5.07% and a negative return on equity of 686.52%.

Separately, Raymond James raised Bausch Health Companies to a “hold” rating in a report on Wednesday, July 10th.

Bausch Health Companies Trading Up 1.4 %

TSE:BHC opened at C$8.13 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 1.23 and a debt-to-equity ratio of 7,583.76. The business’s 50 day moving average is C$9.21 and its two-hundred day moving average is C$10.91. Bausch Health Companies has a 52 week low of C$5.45 and a 52 week high of C$15.43. The company has a market cap of C$2.98 billion, a PE ratio of -4.81, a P/E/G ratio of 0.21 and a beta of 0.90.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.